Attached files
| file | filename |
|---|---|
| EX-32 - BioRestorative Therapies, Inc. | ex-32.htm |
| EX-31.2 - BioRestorative Therapies, Inc. | ex31-2.htm |
| EX-31.1 - BioRestorative Therapies, Inc. | ex31-1.htm |
| EX-21 - BioRestorative Therapies, Inc. | ex21.htm |
| EX-10.83 - BioRestorative Therapies, Inc. | ex10-83.htm |
| EX-10.76 - BioRestorative Therapies, Inc. | ex10-76.htm |
| EX-10.69 - BioRestorative Therapies, Inc. | ex10-69.htm |
| EX-10.67 - BioRestorative Therapies, Inc. | ex10-67.htm |
| EX-10.65 - BioRestorative Therapies, Inc. | ex10-65.htm |
| EX-10.56 - BioRestorative Therapies, Inc. | ex10-56.htm |
| EX-10.04 - BioRestorative Therapies, Inc. | ex10-04.htm |
| 10-K - BioRestorative Therapies, Inc. | form10-k.htm |
Exhibit 23
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in the Registration Statements of BioRestorative Therapies, Inc. (the “Company”) on Form S-8 (File Nos. 333-196299, 333-203310, 333-210555 and 333-214621) of our report dated April 2, 2018, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of BioRestorative Therapies, Inc. and Subsidiaries as of December 31, 2017 and 2016 and for the years then ended, which report is included in this Annual Report on Form 10-K of BioRestorative Therapies, Inc. for the year ended December 31, 2017.
| /s/ Marcum llp | |
| Marcum llp | |
| New York, NY | |
| April 2, 2018 |